Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment / Mancuso, A; Di Paola, Ed; Leone, A; Catalano, Alfonso; Calabrò, F; Cerbone, L; Zivi, A; Messina, C; Alonso, S; Vigna, L; Caristo, R; Sternberg, C. N.. - In: BJU INTERNATIONAL. - ISSN 1464-4096. - 109/2012:(2012), pp. 200-206.
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment
CATALANO, Alfonso;
2012-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
